Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2,716 | $17.87 | $48,535 | 39,293 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 7:57 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 5,434 | $17.9 | $97,269 | 131,461 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:13 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 772 | $24.67 | $19,045 | 22,420 (Direct) | View |
| 2023-11-20 Sale | 2023-11-21 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 5,108 | $22.64 | $115,645 | 60,138 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 7:31 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 10,000 | $29 | $289,970 | 15,682 (Direct) | View |
| 2023-06-08 Sale | 2023-06-12 8:48 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 974 | $25.02 | $24,369 | 24,717 (Direct) | View |
| 2023-05-17 Sale | 2023-05-19 6:48 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 15,310 | $22.5 | $344,475 | 71,469 (Direct) | View |
| 2023-04-06 Sale | 2023-04-07 8:37 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 1,916 | $18.16 | $34,795 | 23,303 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 577 | $18.78 | $10,836 | 6,824 (Direct) | View |
| 2022-06-09 Sale | 2022-06-10 8:51 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 653 | $17.91 | $11,695 | 7,128 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 5:43 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer | 553 | $23.8 | $13,161 | 6,161 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 5,275 | $0 | 39,293 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 7:57 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 115,828 | $0 | 131,461 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:13 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 1,353 | $0 | 22,420 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-21 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 9,912 | $0 | 60,138 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 8:48 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 1,893 | $0 | 24,717 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 6:48 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 29,738 | $0 | 71,469 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-03 9:15 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 117,195 | $0 | 117,195 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 8:37 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 5,275 | $0 | 23,303 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 9:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 1,353 | $0 | 6,824 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 8:51 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 1,893 | $0 | 7,128 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-07 6:49 pm | N/A 2032-04-05 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer | 93,515 | $0 | 93,515 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 5:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer | 1,352 | $0 | 6,161 (Direct) | View |
Ownership | 2021-12-20 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer | 0 | $0 | 152,688 (Direct) | View |